Disease, International and Metabolic Stability

How the AI revolution can accelerate early drug discovery

Drug Target Review

SEPTEMBER 20, 2023

Complex challenges such as metabolic stability or absorption, distribution, metabolism or excretion (ADME) properties could be better predicted, accurately filtering out poor candidates and streamlining discovery. To really benefit from AI, the pharmaceutical industry must be more open to data sharing.

Drugs

Drugs Metabolic Stability Computational Chemistry Pharmaceuticals

Obstacles and innovations of macrocyclic drug development

Drug Target Review

JANUARY 16, 2025

These sites are commonly involved in protein-protein interactions, some of which are key to disease development. Food and Drug Administration (FDA) approved drugs, macrocycles are used to combat a range of diseases, including cancer, viral, fungal and bacterial infections, neurodegenerative and autoimmune diseases.

Drug Development

Drug Development Small Molecule Drugs FDA Approval

Drug Discovery Digest

How the AI revolution can accelerate early drug discovery

Obstacles and innovations of macrocyclic drug development

Webinars

Stay Connected